Isabelle Sansal

Isabelle Sansal has a diverse and extensive work experience in the field of pharmacology. Beginning in 2000, they worked as a Research Scientist at the Dana-Farber Cancer Institute for seven years. Isabelle then joined Syndexa Pharmaceuticals, where they served as a Scientist and later as a Senior Scientist, leading various projects focused on improving glucose homeostasis and screening compounds.

In 2013, Isabelle Sansal joined ImmuneXcite Inc. as a Senior Scientist, working on oncology biotherapeutics and overseeing conjugation procedures and in vitro activity assessment. Isabelle later became the Director of Pharmacology, leading the preclinical in vitro and in vivo pharmacology efforts.

Moving forward, they joined Ohana Biosciences, Inc. in 2018 as the Director of Pharmacology, responsible for scientific and project strategy, managing the team and external collaborations, and driving in vitro and in vivo preclinical pharmacology.

Currently, Isabelle Sansal is working at Alltrna as the Head of Pharmacology, overseeing disease models and directing pharmacology efforts. Isabelle'srole was later expanded to Senior Director.

Isabelle Sansal has a Doctor of Philosophy (Ph.D.) degree in Biochemistry from Pierre and Marie Curie University. Isabelle also has a Post Doctoral Fellowship in Oncology and Cancer Biology from Harvard Medical School.